{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T13:39:24Z","timestamp":1681565964038},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2369-13-140","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T18:21:26Z","timestamp":1351534886000},"source":"Crossref","is-referenced-by-count":9,"title":["Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study"],"prefix":"10.1186","volume":"13","author":[{"given":"Silvia","family":"Chiroli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Mattin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasily","family":"Belozeroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Gioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"issue":"2 Suppl 1","key":"366_CR1","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation: K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266.","journal-title":"Am J Kidney Dis"},{"key":"366_CR2","volume-title":"USRDS 2010 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States","author":"U.S. Renal Data System","year":"2010","unstructured":"U.S. Renal Data System: USRDS 2010 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. 2010, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD"},{"key":"366_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00774-010-0192-1","volume":"29","author":"S Patel","year":"2011","unstructured":"Patel S, Barron JL, Mirzazedeh M, Gallagher H, Hyer S, Cantor T, Fraser WD: Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages. J Bone Miner Metab. 2011, 29: 71-79. 10.1007\/s00774-010-0192-1.","journal-title":"J Bone Miner Metab"},{"issue":"Suppl 113","key":"366_CR4","first-page":"S1","volume":"76","author":"K Disease","year":"2009","unstructured":"Disease K, Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009, 76 (Suppl 113): S1-S130.","journal-title":"Kidney Int"},{"issue":"4 Suppl 3","key":"366_CR5","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation: K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42 (4 Suppl 3): S1-S201.","journal-title":"Am J Kidney Dis"},{"key":"366_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005, 67: 1179-1187. 10.1111\/j.1523-1755.2005.00185.x.","journal-title":"Kidney Int"},{"key":"366_CR7","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.ajkd.2009.02.010","volume":"53","author":"D Goldsmith","year":"2009","unstructured":"Goldsmith D, Kothawala P, Chalian A, Bernal M, Robbins S, Covic A: Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. Am J Kidney Dis. 2009, 53: 1002-1013. 10.1053\/j.ajkd.2009.02.010.","journal-title":"Am J Kidney Dis"},{"key":"366_CR8","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Pr\u00fctz K-G, Young EW, Pisoni RL: Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. 2006, 70: 1358-1366. 10.1038\/sj.ki.5001754.","journal-title":"Kidney Int"},{"key":"366_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1523-1755.2001.060002472.x","volume":"60","author":"MR Davies","year":"2001","unstructured":"Davies MR, Hruska KA: Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 2001, 60: 472-479. 10.1046\/j.1523-1755.2001.060002472.x.","journal-title":"Kidney Int"},{"key":"366_CR10","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1093\/ndt\/gfm370","volume":"22","author":"G Coen","year":"2007","unstructured":"Coen G, Manni M, Mantella D, Pierantozzi A, Balducci A, Cond\u00f2 S, DiGiulio S, Yancovic L, Lippi B, Manca S, et al: Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?. Nephrol Dial Transplant. 2007, 22: 3262-3267. 10.1093\/ndt\/gfm370.","journal-title":"Nephrol Dial Transplant"},{"key":"366_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1744-9987.2010.00822.x","volume":"14","author":"L De Paola","year":"2010","unstructured":"De Paola L, Coppolino G, Bolignano D, Buemi M, Lombardi L: Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study. Ther Apher Dial. 2010, 14: 566-571. 10.1111\/j.1744-9987.2010.00822.x.","journal-title":"Ther Apher Dial"},{"key":"366_CR12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2215\/CJN.02910707","volume":"3","author":"P Raggi","year":"2008","unstructured":"Raggi P, Kleerekoper M: Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008, 3: 836-843. 10.2215\/CJN.02910707.","journal-title":"Clin J Am Soc Nephrol"},{"key":"366_CR13","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","volume":"13","author":"IH De Boer","year":"2002","unstructured":"De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM: The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol. 2002, 13: 2762-2769. 10.1097\/01.ASN.0000034202.91413.EB.","journal-title":"J Am Soc Nephrol"},{"key":"366_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/jarr.2002.34842","volume":"9","author":"JA Coladonato","year":"2002","unstructured":"Coladonato JA, Ritz E: Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patients. Adv Ren Replace Ther. 2002, 9: 193-199. 10.1053\/jarr.2002.34842.","journal-title":"Adv Ren Replace Ther"},{"key":"366_CR15","first-page":"397","volume":"13","author":"MS Joy","year":"2007","unstructured":"Joy MS, Karagiannis PC, Peyerl FW: Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007, 13: 397-411.","journal-title":"J Manag Care Pharm"},{"key":"366_CR16","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004, 15: 2208-2218. 10.1097\/01.ASN.0000133041.27682.A2.","journal-title":"J Am Soc Nephrol"},{"key":"366_CR17","doi-asserted-by":"publisher","first-page":"c54","DOI":"10.1159\/000228076","volume":"113","author":"GT Schumock","year":"2009","unstructured":"Schumock GT, Andress DL, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K: Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract. 2009, 113: c54-c61. 10.1159\/000228076.","journal-title":"Nephron Clin Pract"},{"key":"366_CR18","doi-asserted-by":"publisher","first-page":"c159","DOI":"10.1159\/000099006","volume":"105","author":"S Khan","year":"2007","unstructured":"Khan S: Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities. Nephron Clin Pract. 2007, 105: c159-c164. 10.1159\/000099006.","journal-title":"Nephron Clin Pract"},{"key":"366_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0038-1633841","volume":"43","author":"H Steil","year":"2004","unstructured":"Steil H, Amato C, Carioni C, Kirchgessner J, Marcelli D, Mitteregger A, Moscardo V, Orlandini G, Gatti E: EuCliD\u2013a medical registry. Methods Inf Med. 2004, 43: 83-88.","journal-title":"Methods Inf Med"},{"key":"366_CR20","doi-asserted-by":"publisher","first-page":"c143","DOI":"10.1159\/000319936","volume":"118","author":"AL de Francisco","year":"2011","unstructured":"de Francisco AL, Kim J, Anker SD, Belozeroff V, Canaud B, Chazot C, Dr\u00fceke TB, Eckardt KU, Floege J, Kronenberg F, et al: An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care Hemodialysis Network: results of the ARO study. Nephron Clin Pract. 2011, 118: c143-c154. 10.1159\/000319936.","journal-title":"Nephron Clin Pract"},{"key":"366_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.ajkd.2008.05.020","volume":"52","author":"R Wald","year":"2008","unstructured":"Wald R, Sarnak MJ, Tighiouart H, Cheung AK, Levey AS, Eknoyan G, Miskulin DC: Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2008, 52: 531-540. 10.1053\/j.ajkd.2008.05.020.","journal-title":"Am J Kidney Dis"},{"key":"366_CR22","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2011","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Dr\u00fceke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, et al: Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011, 26: 1948-1955. 10.1093\/ndt\/gfq219.","journal-title":"Nephrol Dial Transplant"},{"issue":"5 Suppl 2","key":"366_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0272-6386(04)01100-X","volume":"44","author":"DA Goodkin","year":"2004","unstructured":"Goodkin DA, Young EW, Kurokawa K, Pr\u00fctz K-G, Levin NW: Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis. 2004, 44 (5 Suppl 2): 16-21.","journal-title":"Am J Kidney Dis"},{"key":"366_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1012597123667","volume":"1","author":"DK Blough","year":"2000","unstructured":"Blough DK, Ramsey SD: Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Method. 2000, 1: 185-202. 10.1023\/A:1012597123667.","journal-title":"Health Serv Outcomes Res Method"},{"key":"366_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/biostatistics\/1.1.35","volume":"1","author":"DY Lin","year":"2000","unstructured":"Lin DY: Linear regression analysis of censored medical costs. Biostatistics. 2000, 1: 35-47. 10.1093\/biostatistics\/1.1.35.","journal-title":"Biostatistics"},{"key":"366_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S: KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the Diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010, 55: 773-799. 10.1053\/j.ajkd.2010.02.340.","journal-title":"Am J Kidney Dis"},{"key":"366_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00774-009-0048-8","volume":"27","author":"DH Smith","year":"2009","unstructured":"Smith DH, Johnson ES, Thorp ML, Yang X, Neil N: Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes. J Bone Miner Metab. 2009, 27: 287-294. 10.1007\/s00774-009-0048-8.","journal-title":"J Bone Miner Metab"},{"key":"366_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM: Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int. 2005, 68: 1793-1800. 10.1111\/j.1523-1755.2005.00596.x.","journal-title":"Kidney Int"},{"key":"366_CR29","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2009101017","volume":"21","author":"KU Eckardt","year":"2010","unstructured":"Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, et al: Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol. 2010, 21: 1765-1775. 10.1681\/ASN.2009101017.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-140\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:45:32Z","timestamp":1548215132000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-140","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]},"article-number":"140"}}